ERNA Stock Analysis: Buy, Sell, or Hold?
ERNA - Ernexa Therapeutics Inc. Common Stock
$3.92
-0.01 (-0.25%)
▼
5d:
-27.81%
30d:
-47.03%
90d:
+1944.86%
HOLD
MODERATE Confidence
Analysis Updated: Jul 27, 2026 12:00 AM ET
Earnings: Aug 12, 2026
15d
Get Alerted When ERNA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ERNA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ERNA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ERNA is currently trading at $3.92, which is considered oversold relative to its 30-day fair value range of $4.95 to $6.91.
Technical Outlook: Technically, ERNA is in a strong uptrend. The price is currently testing key support at $3.83. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ERNA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $30.00 (+663.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ERNA is in a strong uptrend. The price is currently testing key support at $3.83. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ERNA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $30.00 (+663.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.95 -
$6.91
Company Quality Score
49/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: Trading 663.4% below Wall St target ($30.00)
- CAUTION: 5-day price weakness (-27.8%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$4.95 -
$6.91
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.83
Resistance Level
$9.90
Current Trend
Strong Uptrend
Technical data as of
Jul 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.11
Wall Street Target
$30.00
(+663.4%)
Revenue Growth (YoY)
-94.1%
Share & Embed Analysis
Last updated: July 27, 2026 3:26 PM ET
Data refreshes hourly during market hours. Next update: 4:26 PM
Data refreshes hourly during market hours. Next update: 4:26 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ERNA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1079 | 58 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$196 | 46 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 58 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 59 HOLD |
